Non-for-profit org Viva Physicians said yesterday that it will lead a pan-industry effort to study the use of paclitaxel-eluting devices for the treatment of peripheral artery disease in above-the-knee applications.
The initiative comes on the heels of a meta-analysis published in the Journal of the American Heart Association this month showing a potential link between increased long-term mortality outcomes and paclitaxel devices.
Get the full story at our sister site, Drug Delivery Business News.
The post Docs plan industry collab to study paclitaxel devices appeared first on MassDevice.